Last reviewed · How we verify

NCT07134933

The Effects of Erector Spinae Plane Block on Pain Scores in Unilateral Breast Cancer Surgery

Completed NA Last updated 21 August 2025
What this trial tests

NA trial testing ESP (erector spinae plane)block in Erector Spinae Plane Block in 68 participants. Completed in 20 April 2019.

Timeline
25 December 2018
Primary endpoint
1 March 2019
20 April 2019

Quick facts

Lead sponsorInonu University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment68
Start date25 December 2018
Primary completion1 March 2019
Estimated completion20 April 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Inonu University

Who can join

Adults 18 to 65, female only, with Erector Spinae Plane Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The high incidence of breast cancer is increasing the need for oncologic breast surgery. The optimal acute postoperative pain management after breast surgery is not yet clear. The erector spinae plane block (ESPB) is a newer and may be potentially safer alternative other regional analgesia techniques. We will investigate the effectiveness of ESP for managing acute pain after breast cancer surgery. Patients will randomise to receive either ESP block (Group1)or no ESP block (Group II). The primary outcome is postoperative pain scores used Visual Analog Scale (VAS), and the secondary outcomes include intraoperative opioid consumption postoperative total opioid consumption and patient satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Erector Spinae Plane Block

Currently open trials in the same condition.

Other Inonu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07134933.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing